Capital Advisors Ltd’s Advent Technologies ADN Stock Holding History

Capital Advisors Ltd’s Portfolio ADN Stock Details ADN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-39	Closed	–	–	1346
2024 Q1	$0	Buy	+39	New	+$214	﹤0.01%	1324

Other funds holding ADN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

SSG

Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return

AIC

Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return

Capital Advisors Ltd's ADN Position: Q2 2024 in Review

Capital Advisors Ltd sold out of Advent Technologies (ADN) in Q2 2024, closing a stake of 39 shares.

Capital Advisors Ltd first reported a position in ADN in Q1 2024 and held it in 1 quarter. The position peaked at $0 in Q1 2024. 15 funds tracked by Wall St. Rank hold ADN as of Q2 2024.

Capital Advisors Ltd reported no remaining Advent Technologies position as of Q2 2024 after selling out during the quarter.
Capital Advisors Ltd sold 39 Advent Technologies shares in Q2 2024.
Capital Advisors Ltd first reported a position in Advent Technologies in Q1 2024 and held it in 1 quarter.
Capital Advisors Ltd's Advent Technologies position peaked at $0 in Q1 2024.
15 funds tracked by Wall St. Rank held Advent Technologies as of Q2 2024.

Based on Capital Advisors Ltd's 13F filing for Q2 2024, filed 25 Jul 2024.